Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis

被引：0

作者：

Hauser, Stephen ^{[1
]}

Kappos, Ludwig ^{[2
]}

Montalban, Xavier ^{[3
]}

Chognot, Cathy ^{[4
]}

Jessop, Nikki ^{[4
]}

Kadner, Karen ^{[4
]}

Pradhan, Ashish ^{[5
]}

Incera, Elodie ^{[6
]}

Wolinsky, Jerry ^{[7
]}

机构：

[1] Univ Calif San Francisco, UCSF Weill Inst Neurosci, San Francisco, CA USA

[2] Univ Hosp Basel, Res Ctr Clin Neuroimmunol & Neurosci, Basel, Switzerland

[3] Vall Hebron Univ Hosp, Dept Neurol Neuroimmunol, Multiple Sclerosis Ctr Catalonia, Barcelona, Spain

[4] F Hoffmann La Roche Ltd, Basel, Switzerland

[5] Genentech Inc, South San Francisco, CA USA

[6] IQVIA Inc, Paris, France

[7] Univ Texas Hlth Sci Ctr Houston UTHlth, McGovern Med Sch, Houston, TX USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P304/524

引用

页码：352 / 353

页数：2